Details of the Drug
General Information of Drug (ID: DMZW9AC)
| Drug Name |
N-Acetylalanine
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Synonyms |
N-Acetyl-DL-alanine; 1115-69-1; 2-acetamidopropanoic acid; Ac-DL-Ala-OH; 2-Acetylaminopropionic acid; N-ACETYLALANINE; Acetyl-DL-Alanine; DL-Alanine, N-acetyl-; N-alpha-Acetyl-DL-alanine; 2-Acetylamino-propionic acid; N-Acetyl-S-alanine; L-Alanine, N-acetyl-; KTHDTJVBEPMMGL-UHFFFAOYSA-N; N-Acetyl-DL-2-aminopropionic Acid; 2-(acetylamino)propanoic acid; n-acetylalanin; Alanine, N-acetyl-; Alanine, N-acetyl-, L-; L-Alanine, N-acetyl- (9CI); Alanine, N-acetyl-, L- (8CI); ac-dl-alanine; n-acetyl-dl-ala; N-Acetylalanine #; EINECS 214-
|
||||||||||||||||||
| Indication |
|
||||||||||||||||||
| Drug Type |
Small molecular drug
|
||||||||||||||||||
| Structure |
![]() |
||||||||||||||||||
| 3D MOL | 2D MOL | ||||||||||||||||||
| #Ro5 Violations (Lipinski): 0 | Molecular Weight (mw) | 131.13 | |||||||||||||||||
| Logarithm of the Partition Coefficient (xlogp) | -0.9 | ||||||||||||||||||
| Rotatable Bond Count (rotbonds) | 2 | ||||||||||||||||||
| Hydrogen Bond Donor Count (hbonddonor) | 2 | ||||||||||||||||||
| Hydrogen Bond Acceptor Count (hbondacc) | 3 | ||||||||||||||||||
| Chemical Identifiers |
|
||||||||||||||||||
| Cross-matching ID | |||||||||||||||||||
| Drug-Molecule Activity Atlas (DMA)NEW | Click to Jump to the Detailed DMA Information of This Drug | ||||||||||||||||||
Molecular Interaction Atlas of This Drug
![]() Drug Therapeutic Target (DTT) |
|
||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Molecular Interaction Atlas (MIA) | |||||||||||||||||||||
Molecular Expression Atlas of This Drug
| The Studied Disease | Discovery agent | |||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ICD Disease Classification | N.A. | |||||||||||||||||
|
||||||||||||||||||
| Molecular Expression Atlas (MEA) | ||||||||||||||||||


